[Antibodies to adrenaline and noradrenaline in neurologic diseases].
It has been established that some patients with organic lesions of the nervous system develop intensive immunological reaction to catecholamines. The presence in such patients of antibodies to adrenaline and noradrenaline is indicative of considerable disruption of catecholamine biotransformation.
D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000276:immunology; D001323:Autoantibodies / Q000032:analysis*; D001927:Brain Diseases / Q000276:immunology; D004660:Encephalitis / Q000276:immunology; D004837:Epinephrine / Q000276:immunology*; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D008297:Male; D008875:Middle Aged; D009136:Muscular Dystrophies / Q000276:immunology; D009422:Nervous System Diseases / Q000276:immunology*; D009638:Norepinephrine / Q000276:immunology*; D010302:Parkinson Disease, Secondary / Q000276:immunology; D012559:Schizophrenia / Q000276:immunology; D013595:Syringomyelia / Q000276:immunology
D001323:Autoantibodies; D009638:Norepinephrine; D004837:Epinephrine
Antitela k adrenalinu i noradrenalinu pri nevrologicheskikh zabolevaniiakh.